CRISPR Therapeutics AG is a biotechnology company focused on the development and commercialization of gene-based medicines aimed primarily at treating serious diseases using CRISPR/Cas9 gene-editing technologies.
No data available
Are you interested in the impact of this stock or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!